Bacteria treatment study for liver disease patients
Part of Digestive system clinical trials.
This trial tests whether giving a mixture of helpful bacteria can improve gut health in people hospitalized with serious liver problems. It aims to see if restoring these bacteria can help with recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with liver disease, liver failure, or cirrhosis.
- You are currently hospitalized for a worsening of your liver condition.
- Your liver function score (MELD) is 30 or lower.
- You are not on antibiotics for an infection right now.
- You do not have a condition like active inflammatory bowel disease or a history of a total colectomy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the bacteria in your gut (microbiome) and how your body responds to liver disease. Researchers want to learn if these factors can help improve care for people with liver problems.
This trial studies fecal microbiota transplantation (a transfer of healthy gut bacteria from a donor) to help people with worsening liver failure. It may help by changing gut bacteria, which can affect complications like confusion, fluid buildup, infections, and kidney problems.
This study looks at the bacteria in the gut of people with liver cirrhosis to better understand how they relate to the disease. By joining, you help researchers learn more about cirrhosis, which may lead to better care in the future.
This study looks at how gut bacteria change in people with liver cirrhosis and whether these changes relate to how the disease progresses. It may help find new ways to monitor or treat cirrhosis.
This trial studies whether transferring healthy gut bacteria (from a donor sample) can improve outcomes for people with liver cirrhosis who have worsening complications. It may help by changing the gut microbiome, which can influence inflammation and liver health.
This study tests whether adding a probiotic to standard antibiotics helps treat an infection in the abdominal fluid of people with cirrhosis (called spontaneous bacterial peritonitis) and prevents it from coming back.
Hear when a new Liver Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.